ChartRow logo
BTSG
$69.80-0.06%
as of close, Nov 4, 2026
☾ AH $69.80 -0.06%
PeersTEMCRBGREGFHNALBSMCI
Share this page

BTSG SEC filings (2026)

CIK 1865782 · Services-Home Health Care Services (SIC 8082) · incorporated in DE · fiscal year ends in December

238 filings on EDGAR since 2021 · 3 annual, 9 quarterly, 35 current · financial statements · earnings

Latest 10-K
Feb 27, 2026
fiscal year to Dec 31, 2025
Latest 10-Q
Oct 30, 2026
quarter to Sep 30, 2026
Latest 8-K
Oct 30, 2026
BrightSpring Health Services, Inc. Reports Third Quarter 2026 Financial Results and Increases Full Year 2026 Guidance
Last earnings release
Oct 30, 2026
$0.54 vs $0.45 · ▲ 11.1%
Filings on file
238
since 2021, 113 insider forms

What happened, last 12 months#

Every earnings release with its print, every report with its quarter, the other 8-Ks by the headline of the press release they furnish or by their items, the proxy statements, and each day an insider bought or sold — newest first, each line opening the filing on EDGAR. The index by form and year follows.

October 2026

September 2026

July 2026

June 2026

May 2026

April 2026

March 2026

February 2026

Insider transactions#

What officers, directors and 10% holders reported on Forms 4 and 5 over the last 13 months, from the documents themselves: one insider’s trades of one kind on one day are one row, with the shares, the price range and the total as filed. Open-market buys and sells first; awards, exercises, tax withholding, gifts and employee-plan purchases are grouped below them.

Over the last 13 months insiders sold $3.36B in 11 sales and bought nothing on the open market; 48 other transactions (awards, exercises, tax withholding, gifts and plan purchases).

DateInsider
Sep 14, 2026Form 4Greenwell Scott A.President, PharMericaSold · $874K · 15,099 sh · 10b5-1
Jun 5, 2026Form 4KKR Phoenix Aggregator L.P., KKR Phoenix Aggregator GP LLC, KKR Americas Fund XII L.P., KKR Associates Americas XII L.P., KKR Americas XII Ltd5 filersSold · $857.5M · 14,669,771 sh
Jun 5, 2026Form 4KKR Group Partnership L.P., KKR Group Holdings Corp., KKR Group Co. Inc., KKR & Co. Inc., KKR Management LLP, KRAVIS HENRY R, ROBERTS GEORGE R7 filersSold · $857.5M · 14,669,771 sh
Jun 5, 2026Form 4ROUSSEAU JON BSee Remarks · DirectorSold · $15.3M · 260,000 sh
Jun 5, 2026Form 4Phipps Jennifer AChief Financial OfficerSold · $2.1M · 35,000 sh
Jun 5, 2026Form 4Nalley Lisa ASee RemarksSold · $2.1M · 35,000 sh
Mar 4, 2026Form 4KKR Phoenix Aggregator L.P., KKR Phoenix Aggregator GP LLC, KKR Americas Fund XII L.P., KKR Associates Americas XII L.P., KKR Americas XII Ltd5 filersSold · $807.5M · 19,715,000 sh
Mar 4, 2026Form 4KKR Group Partnership L.P., KKR Group Holdings Corp., KKR Group Co. Inc., KKR & Co. Inc., KKR Management LLP, KRAVIS HENRY R, ROBERTS GEORGE R7 filersSold · $807.5M · 19,715,000 sh
Mar 4, 2026Form 4ROUSSEAU JON BSee Remarks · DirectorSold · $9.1M · 220,000 sh
Mar 4, 2026Form 4Phipps Jennifer AChief Financial OfficerSold · $1.4M · 35,000 sh
Mar 4, 2026Form 4Nalley Lisa ASee RemarksSold · $1.2M · 30,000 sh
Awards, exercises, withholding and plan purchases · 48 transactions
DateInsider
Oct 25, 2026Form 4ROUSSEAU JON BSee Remarks · DirectorTax withholding · $2.2M · 36,355 sh
Sep 14, 2026Form 4Greenwell Scott A.President, PharMericaExercise or conversion · $267K · 11,973 sh · 10b5-1
Sep 14, 2026Form 4Greenwell Scott A.President, PharMericaExercise or conversion · Stock Options (Right to Buy) · $0 · 11,973 sh · 10b5-1
Jul 25, 2026Form 4ROUSSEAU JON BSee Remarks · DirectorTax withholding · $4.1M · 56,319 sh
Jun 20, 2026Form 4Greenwell Scott A.President, PharMericaTax withholding · $165K · 2,487 sh
Jun 11, 2026Form 4Shah Nigam H.DirectorAward · $0 · 4,013 sh
Jun 5, 2026Form 4ROUSSEAU JON BSee Remarks · DirectorExercise or conversion · $1.7M · 260,000 sh
Jun 5, 2026Form 4Phipps Jennifer AChief Financial OfficerExercise or conversion · $223K · 35,000 sh
Jun 5, 2026Form 4Nalley Lisa ASee RemarksExercise or conversion · $223K · 35,000 sh
Jun 5, 2026Form 4KKR Phoenix Aggregator L.P., KKR Phoenix Aggregator GP LLC, KKR Americas Fund XII L.P., KKR Associates Americas XII L.P., KKR Americas XII Ltd5 filersOther · $0 · 324,608 sh
Jun 5, 2026Form 4KKR Group Partnership L.P., KKR Group Holdings Corp., KKR Group Co. Inc., KKR & Co. Inc., KKR Management LLP, KRAVIS HENRY R, ROBERTS GEORGE R7 filersOther · $0 · 324,608 sh
Jun 5, 2026Form 4ROUSSEAU JON BSee Remarks · DirectorExercise or conversion · Stock Options (Right to Buy) · $0 · 260,000 sh
Jun 5, 2026Form 4KKR Phoenix Aggregator L.P., KKR Phoenix Aggregator GP LLC, KKR Americas Fund XII L.P., KKR Associates Americas XII L.P., KKR Americas XII Ltd5 filersGift · $0 · 60,190 sh
Jun 5, 2026Form 4KKR Group Partnership L.P., KKR Group Holdings Corp., KKR Group Co. Inc., KKR & Co. Inc., KKR Management LLP, KRAVIS HENRY R, ROBERTS GEORGE R7 filersGift · $0 · 60,190 sh
Jun 5, 2026Form 4Phipps Jennifer AChief Financial OfficerExercise or conversion · Stock Options (Right to Buy) · $0 · 35,000 sh
Jun 5, 2026Form 4Nalley Lisa ASee RemarksExercise or conversion · Stock Options (Right to Buy) · $0 · 35,000 sh
May 5, 2026Form 4Wicks Timothy ADirectorAward · $0 · 4,983 sh
May 5, 2026Form 4KIRTLEY OLIVIA FDirectorAward · $0 · 4,983 sh
May 5, 2026Form 4Miller Steven BDirectorAward · $0 · 4,983 sh
Apr 25, 2026Form 4ROUSSEAU JON BSee Remarks · DirectorTax withholding · $781K · 16,222 sh
Mar 30, 2026Form 4Barnes Robert AllenPresident, Community LivingTax withholding · $280K · 6,748 sh
Mar 20, 2026Form 4ROUSSEAU JON BSee Remarks · DirectorGift · Stock Options (Right to Buy) · $0 · 1,132,322 sh
Mar 5, 2026Form 4ROUSSEAU JON BSee Remarks · DirectorAward · Stock Options (Right to Buy) · $0 · 458,008 sh
Mar 5, 2026Form 4ROUSSEAU JON BSee Remarks · DirectorAward · $0 · 186,845 sh
Mar 5, 2026Form 4Phipps Jennifer AChief Financial OfficerAward · Stock Options (Right to Buy) · $0 · 130,860 sh
Mar 5, 2026Form 4Phipps Jennifer AChief Financial OfficerAward · $0 · 53,384 sh
Mar 5, 2026Form 4Nalley Lisa ASee RemarksAward · Stock Options (Right to Buy) · $0 · 52,344 sh
Mar 5, 2026Form 4Greenwell Scott A.President, PharMericaAward · Stock Options (Right to Buy) · $0 · 49,073 sh
Mar 5, 2026Form 4Nalley Lisa ASee RemarksAward · $0 · 21,354 sh
Mar 5, 2026Form 4Greenwell Scott A.President, PharMericaAward · $0 · 20,020 sh
Mar 4, 2026Form 4ROUSSEAU JON BSee Remarks · DirectorExercise or conversion · $1.4M · 220,000 sh
Mar 4, 2026Form 4Phipps Jennifer AChief Financial OfficerExercise or conversion · $223K · 35,000 sh
Mar 4, 2026Form 4Nalley Lisa ASee RemarksExercise or conversion · $191K · 30,000 sh
Mar 4, 2026Form 4ROUSSEAU JON BSee Remarks · DirectorAward · Stock Options (Right to Buy) · $0 · 955,823 sh
Mar 4, 2026Form 4KKR Phoenix Aggregator L.P., KKR Phoenix Aggregator GP LLC, KKR Americas Fund XII L.P., KKR Associates Americas XII L.P., KKR Americas XII Ltd5 filersOther · $0 · 402,773 sh
Mar 4, 2026Form 4KKR Group Partnership L.P., KKR Group Holdings Corp., KKR Group Co. Inc., KKR & Co. Inc., KKR Management LLP, KRAVIS HENRY R, ROBERTS GEORGE R7 filersOther · $0 · 402,773 sh
Mar 4, 2026Form 4ROUSSEAU JON BSee Remarks · DirectorExercise or conversion · Stock Options (Right to Buy) · $0 · 220,000 sh
Mar 4, 2026Form 4KKR Phoenix Aggregator L.P., KKR Phoenix Aggregator GP LLC, KKR Americas Fund XII L.P., KKR Associates Americas XII L.P., KKR Americas XII Ltd5 filersGift · $0 · 81,213 sh
Mar 4, 2026Form 4KKR Group Partnership L.P., KKR Group Holdings Corp., KKR Group Co. Inc., KKR & Co. Inc., KKR Management LLP, KRAVIS HENRY R, ROBERTS GEORGE R7 filersGift · $0 · 81,213 sh
Mar 4, 2026Form 4Phipps Jennifer AChief Financial OfficerAward · Stock Options (Right to Buy) · $0 · 41,219 sh
Mar 4, 2026Form 4Nalley Lisa ASee RemarksAward · Stock Options (Right to Buy) · $0 · 39,256 sh
Mar 4, 2026Form 4Phipps Jennifer AChief Financial OfficerExercise or conversion · Stock Options (Right to Buy) · $0 · 35,000 sh
Mar 4, 2026Form 4Nalley Lisa ASee RemarksExercise or conversion · Stock Options (Right to Buy) · $0 · 30,000 sh
Mar 3, 2026Form 4Barnes Robert AllenPresident, Community LivingAward · Stock Options (Right to Buy) · $0 · 38,275 sh
Jan 25, 2026Form 4ROUSSEAU JON BSee Remarks · DirectorTax withholding · $2.0M · 49,304 sh
Jan 25, 2026Form 4Phipps Jennifer AChief Financial OfficerTax withholding · $1.3M · 33,190 sh
Jan 25, 2026Form 4Nalley Lisa ASee RemarksTax withholding · $815K · 20,556 sh
Jan 25, 2026Form 4Barnes Robert AllenPresident, Community LivingTax withholding · $276K · 6,972 sh

Reports and proxy statements#

Annual reports (10-K, 20-F, 40-F), quarterly reports (10-Q), current reports (8-K, 6-K) and proxy statements, newest first. An 8-K that furnishes a press release is headed by the release’s headline, its items beneath; any other 8-K is described by its items. A form opens the press release where there is one, else the document on EDGAR, or the filing’s index where it furnishes other exhibits.

2026 · 16 filings
FiledWhat it is
Oct 30, 202610-QQuarterly report, Q3 2026 — revenue $4.21B (+26% y/y), net income $100.1M, EPS $0.45
Oct 30, 20268-KEarnings release — EPS $0.54 vs $0.45 est. (+20.0%); revenue $4.21B (+26% y/y) 11.1%
Jul 31, 202610-QQuarterly report, Q2 2026 — revenue $3.87B (+23% y/y), net income $84.3M, EPS $0.38
Jul 31, 20268-KEarnings release — EPS $0.45 vs $0.37 est. (+21.6%); revenue $3.87B (+23% y/y) 18.1%
Jun 12, 20268-KBrightSpring Health Services, Inc. Welcomes Dr. Nigam H. Shah to Board of DirectorsDirectors or officers; compensation; Regulation FD disclosure
Jun 5, 20268-KMaterial definitive agreement
May 21, 20268-KShareholder vote results
May 1, 202610-QQuarterly report, Q1 2026 — revenue $3.61B (+26% y/y), net income $148.8M, EPS $0.67
May 1, 20268-KEarnings release — EPS $0.39 vs $0.29 est. (+34.5%); revenue $3.61B (+26% y/y) 9.6%
Apr 10, 2026ARSAnnual report to shareholders
Apr 10, 2026DEFA14AAdditional proxy materials
Apr 10, 2026DEF 14AProxy statement
Mar 31, 20268-KBrightSpring Health Services Completes Sale of ResCare Community Living to SevitaCompletion of an acquisition or disposition; Directors or officers; compensation; Regulation FD disclosure
Mar 4, 20268-KMaterial definitive agreement
Feb 27, 202610-KAnnual report, FY2025 — revenue $12.91B (+28% y/y), net income $190.7M, EPS $0.87
Feb 27, 20268-KEarnings release — EPS $0.33 vs $0.34 est. (−2.9%); revenue $3.55B (+29% y/y) 3.2%
2025 · 21 filings
FiledWhat it is
Oct 28, 202510-QQuarterly report, Q3 2025 — revenue $3.33B (+28% y/y), net income $55.8M, EPS $0.26
Oct 28, 20258-KBrightSpring Health Services, Inc. Reports Third Quarter 2025 Financial Results and Increases Full Year 2025 GuidanceResults of operations
Oct 22, 20258-KMaterial definitive agreement
Oct 20, 20258-KEarnings release — EPS $0.30 vs $0.27 est. (+11.1%); revenue $3.33B (+28% y/y) 5.8%
Aug 1, 202510-QQuarterly report, Q2 2025 — revenue $3.15B (+29% y/y), net income $28.2M, EPS $0.13
Aug 1, 20258-KEarnings release — EPS $0.22 vs $0.19 est. (+15.8%); revenue $3.15B (+29% y/y) 4.9%
Jun 20, 20258-KDirectors or officers; compensation
Jun 12, 20258-KMaterial definitive agreement
Jun 10, 20258-KOther events
Jun 3, 20258-KShareholder vote results
May 5, 2025DEFA14AAdditional proxy materials
May 2, 202510-QQuarterly report, Q1 2025 — revenue $2.88B (+26% y/y), net income $29.5M, EPS $0.14
May 2, 20258-KEarnings release — EPS $0.19 vs $0.08 est. (+137.5%); revenue $2.88B (+26% y/y) 16.6%
Apr 18, 2025ARSAnnual report to shareholders
Apr 18, 2025DEFA14AAdditional proxy materials
Apr 18, 2025DEF 14AProxy statement
Apr 15, 20258-K/ADirectors or officers; compensation
Mar 6, 202510-KAnnual report, FY2024 — revenue $10.07B (+31% y/y), net income −$18.1M, EPS −$0.09
Mar 6, 20258-KEarnings release — EPS $0.22 vs $0.19 est. (+15.8%); revenue $2.75B (+122% y/y) 6.3%
Mar 5, 20258-KDirectors or officers; compensation; Regulation FD disclosure
Jan 21, 20258-KMaterial definitive agreement; Regulation FD disclosure
2024 · 17 filings
FiledWhat it is
Dec 11, 20248-KMaterial definitive agreement; New financial obligation; Regulation FD disclosure
Nov 15, 20248-KDirectors or officers; compensation
Nov 1, 202410-QQuarterly report, Q3 2024 — revenue $2.60B (+15% y/y), net income −$8.2M, EPS −$0.04
Nov 1, 20248-KEarnings release — EPS $0.11 vs $0.18 est. (−38.9%); revenue $2.60B (+15% y/y) 15.2%
Oct 11, 20248-KDirectors or officers; compensation
Sep 30, 20248-KDirectors or officers; compensation; Regulation FD disclosure
Aug 2, 202410-QQuarterly report, Q2 2024 — revenue $2.44B (+13% y/y), net income $19.9M, EPS $0.10
Aug 2, 20248-KEarnings release — EPS $0.10 vs $0.18 est. (−44.4%); revenue $2.44B (+13% y/y) 8.7%
Jun 24, 20248-KUnregistered sale of equity
May 31, 20248-KDirectors or officers; compensation
May 2, 202410-QQuarterly report, Q1 2024 — revenue $2.29B (+13% y/y), net income −$45.8M, EPS −$0.26
May 2, 20248-KEarnings release — EPS $0.12 vs $0.06 est. (+100.0%); revenue $2.29B (+13% y/y) 3.8%
Apr 26, 20248-KDirectors or officers; compensation
Mar 6, 202410-KAnnual report
Feb 29, 20248-KEarnings release — EPS −$0.06 vs $0.15 est. (−140.0%) 7.6%
Feb 23, 20248-KMaterial definitive agreement; New financial obligation
Jan 30, 20248-KMaterial definitive agreement; Termination of a material agreement; Change to security holders' rights; Directors or officers; compensation; Charter, bylaws or fiscal-year change; Other events

Insider, ownership and other filings#

Insider ownership (Forms 3, 4, 5 and 144), beneficial ownership (Schedules 13D and 13G), registration and prospectus (S-1, S-3, S-8, 424B and related) and the rest, counted by year, with the newest 25 of each of the latest 3 years shown. A Form 4 is one insider’s transaction report; a 13G is a passive holder above five percent.

2026 · 47 filings — 27 × 4, 8 × SCHEDULE 13G/A, 4 × 424B7 and 4 other forms
FiledWhat it is
Oct 30, 2026SCHEDULE 13G/AOther filings
Oct 27, 20264Insider transaction (Form 4)
Sep 16, 20264Insider transaction (Form 4)
Sep 14, 2026144Notice of proposed sale (Form 144)
Aug 6, 2026SCHEDULE 13G/AOther filings
Jul 31, 2026SCHEDULE 13GOther filings
Jul 28, 20264Insider transaction (Form 4)
Jul 27, 2026SCHEDULE 13G/AOther filings
Jun 22, 20264Insider transaction (Form 4)
Jun 12, 20264Insider transaction (Form 4)
Jun 12, 20263Initial insider holdings (Form 3)
Jun 5, 2026SCHEDULE 13D/AOther filings
Jun 5, 20264Insider transaction (Form 4)
Jun 5, 20264Insider transaction (Form 4)
Jun 5, 20264Insider transaction (Form 4)
Jun 5, 20264Insider transaction (Form 4)
Jun 5, 20264Insider transaction (Form 4)
Jun 5, 2026424B7Registration and prospectus
Jun 3, 2026424B7Registration and prospectus
Jun 3, 2026144Notice of proposed sale (Form 144)
Jun 2, 2026144Notice of proposed sale (Form 144)
May 7, 20264Insider transaction (Form 4)
May 7, 20264Insider transaction (Form 4)
May 7, 20264Insider transaction (Form 4)
May 6, 2026SCHEDULE 13G/AOther filings

The newest 25 of 47 shown; the full year is on EDGAR.

2025 · 53 filings — 34 × 4, 4 × 424B7, 4 × SCHEDULE 13G/A and 6 other forms
FiledWhat it is
Nov 14, 2025SCHEDULE 13GOther filings
Nov 12, 20254/AInsider transaction (Form 4), amended
Nov 6, 20254Insider transaction (Form 4)
Oct 28, 20254Insider transaction (Form 4)
Oct 22, 20254Insider transaction (Form 4)
Oct 22, 20254Insider transaction (Form 4)
Oct 22, 2025SCHEDULE 13D/AOther filings
Oct 22, 20254Insider transaction (Form 4)
Oct 22, 20254Insider transaction (Form 4)
Oct 21, 2025424B7Registration and prospectus
Oct 20, 2025424B7Registration and prospectus
Aug 14, 2025144Notice of proposed sale (Form 144)
Aug 7, 2025SCHEDULE 13GOther filings
Jul 29, 20254Insider transaction (Form 4)
Jul 29, 20254Insider transaction (Form 4)
Jul 29, 2025SCHEDULE 13GOther filings
Jun 27, 20253Initial insider holdings (Form 3)
Jun 26, 2025SCHEDULE 13D/AOther filings
Jun 26, 20254Insider transaction (Form 4)
Jun 26, 20254Insider transaction (Form 4)
Jun 16, 20254Insider transaction (Form 4)
Jun 16, 20254Insider transaction (Form 4)
Jun 13, 20254Insider transaction (Form 4)
Jun 13, 20254Insider transaction (Form 4)
Jun 13, 20254Insider transaction (Form 4)

The newest 25 of 53 shown; the full year is on EDGAR.

2024 · 67 filings — 25 × 4, 18 × 3, 5 × CORRESP and 13 other forms
FiledWhat it is
Nov 14, 2024SC 13GPassive holder above 5% (Schedule 13G)
Nov 8, 20244Insider transaction (Form 4)
Nov 8, 20243Initial insider holdings (Form 3)
Nov 8, 2024SC 13GPassive holder above 5% (Schedule 13G)
Oct 29, 20244Insider transaction (Form 4)
Oct 7, 2024SC 13GPassive holder above 5% (Schedule 13G)
Sep 18, 2024SC 13DActive holder above 5% (Schedule 13D)
Sep 16, 2024DOther filings
Sep 13, 20244Insider transaction (Form 4)
Sep 13, 20244Insider transaction (Form 4)
Sep 13, 20244Insider transaction (Form 4)
Jul 26, 20244Insider transaction (Form 4)
May 21, 20244Insider transaction (Form 4)
May 13, 20244Insider transaction (Form 4)
May 7, 20244Insider transaction (Form 4)
May 7, 20244Insider transaction (Form 4)
Apr 30, 20243Initial insider holdings (Form 3)
Apr 26, 20244Insider transaction (Form 4)
Mar 18, 20244Insider transaction (Form 4)
Mar 18, 20244Insider transaction (Form 4)
Mar 18, 20244Insider transaction (Form 4)
Mar 18, 20244/AInsider transaction (Form 4), amended
Mar 15, 20244Insider transaction (Form 4)
Mar 15, 20244Insider transaction (Form 4)
Mar 15, 20244Insider transaction (Form 4)

The newest 25 of 67 shown; the full year is on EDGAR.

2023 · 9 filings — 3 × DRS/A, 3 × DRSLTR, 2 × UPLOAD and 1 other form

Counted, not listed; the year is on EDGAR.

2022 · 3 filings — 2 × S-1/A, 1 × RW

Counted, not listed; the year is on EDGAR.

2021 · 5 filings — 2 × DRS/A, 1 × DRS, 1 × S-1 and 1 other form

Counted, not listed; the year is on EDGAR.

About this data#

BrightSpring Health Services Inc. (BTSG) has 238 filings on EDGAR going back to 2021: 3 annual reports, 9 quarterly reports and 35 current reports, plus proxy statements, insider forms and ownership schedules. Its latest annual report, a 10-K, was filed on Feb 27, 2026 for the fiscal year ended Dec 31, 2025. The most recent 8-K, on Oct 30, 2026, furnished a press release headed “BrightSpring Health Services, Inc. Reports Third Quarter 2026 Financial Results and Increases Full Year 2026 Guidance”. Over the last 13 months insiders sold $3.36B in 11 sales and bought nothing on the open market; 48 other transactions (awards, exercises, tax withholding, gifts and plan purchases). Not investment advice.

Every row is a filing EDGAR lists for the registrants that have been BrightSpring Health Services Inc., read from the SEC’s submissions index each morning; a filing accepted after that read appears the next day. Where a company changed its filing entity (a holding-company reorganisation, Google into Alphabet) the predecessor’s filings are shown for the years it filed as the company, derived from the filings themselves. Dates are the filing date; the period is the report’s own. The latest 3 years of reports are listed in full, the next years to 10 without their 8-Ks, and older years are counted; the other forms are counted too, with the newest 25 of each of the latest 3 years shown. Insider transactions are the Form 4 and Form 5 documents themselves, filed since January 2026, every number as the insider filed it: a day’s lots are summed, a blank price adds its shares and no dollars, and a purchase through an employee stock plan is a plan purchase, not insider buying. An 8-K’s headline is the first line of the press release it furnishes (Exhibit 99), read from the filing and shown word for word; where two independent readings of the exhibit do not agree, the 8-K is described by its items instead. The documents stay on sec.gov, public domain, and every link opens the SEC’s copy. ChartRow does not summarise or interpret filings.

FAQ#

Where can I read BTSG's latest 10-K?
BTSG's latest annual report, a 10-K, was filed on Feb 27, 2026 for the fiscal year ended Dec 31, 2025. It is linked above and opens on EDGAR, the SEC's own site, where every exhibit is also listed.
When did BTSG last file an 8-K?
On Oct 30, 2026 it furnished a press release headed “BrightSpring Health Services, Inc. Reports Third Quarter 2026 Financial Results and Increases Full Year 2026 Guidance”. An 8-K reports a material event between quarterly reports; the one that furnishes the quarter's results is filed under Item 2.02, last on Oct 30, 2026.
Are BTSG insiders buying or selling?
Over the last 13 months insiders sold $3.36B in 11 sales and bought nothing on the open market; 48 other transactions (awards, exercises, tax withholding, gifts and plan purchases). The most recent sale: Greenwell Scott A. (President, PharMerica) sold 15,099 shares on Sep 14, 2026 for $874K, under a 10b5-1 plan. Every figure is as the insider filed it on Form 4; a sale under a 10b5-1 plan was scheduled in advance.
How many SEC filings has BTSG made?
238 filings are on EDGAR under the registrant records that have been BrightSpring Health Services Inc., going back to 2021; 113 of them are insider ownership forms (Forms 3, 4, 5 and 144).